Table II.
Indications for warfarin, INR targets, and median INRs in the study patients
| Indication for warfarin | n (%) |
|---|---|
| AF without mechanical valve | 156 (62.6) |
| Mechanical valve | 25 (10.0) |
| LA or LV thrombus | 12 (4.8) |
| DVT, PE or DVT prophylaxis | 54 (21.6) |
| Unclear | 2 (0.8) |
| Target INR | |
| 2.0-3.0 | 221 (88.8) |
| 2.5-3.5 | 28 (11.2) |
| INR (target 2-3), median (IQR) | 1.7 (1.2-2.4) |
| INR (target 2.5-3.5), median (IQR) | 2.1 (1.6-2.8) |
| INRs per person, median (IQR) | 9 (3-19) |
AF, atrial fibrillation; LA, left atrial; LV, left ventricular; DVT, deep-vein thrombosis; PE, pulmonary embolism; INR, international normalized ratio